Among the AML patients included in the study, the presence of an FLT3 mutation was associated with a significantly elevated white blood cell count at diagnosis (82.90 G/L vs. 20.36 G/L, p = 0.001). The gene discussed is FLT3; the disease is acute myeloid leukemia.